|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 美国临床生化科学院检验医学实践指南:睾丸、前列腺、结直肠、乳腺及卵巢癌肿瘤标志物的应用显示文摘经美国临床生化科学院(NCAB)授权,由鄢盛恺教授组织学者、专家翻译审定2009年NCAB检验医学实践指南:睾丸、前列腺、结直肠、乳腺及卵巢癌中肿瘤标志物的应用单行本(Catharine M.Sturgeon教授和Eleftherios P.Diaman-dis教授编辑)。该指南包含第1至6章共6部分内容,参加指南制订的专家阵容强大,分别从临床及检验角度对睾丸、前列腺、结直肠、乳腺及卵巢癌中肿瘤标志物的检测与临床应用方面的问题进行了详细阐述与说明,是目前国内外在肿瘤实验诊断方面的纲领性应用文件。不仅适合广大检验人员、临床医护人员学习使用,也非常适合相关仪器试剂生产厂商研发应用。本指南由刘洋、薛丽、林文涛、李江、梁红艳、顾兵、潘世扬、郑磊等翻译,姜晓峰、沈文梅、田亚平、鄢盛恺审校,最后由鄢盛恺统稿审定。本指南的翻译出版,不仅有助于我国检验人员和医护人员合理的检测和应用睾丸、前列腺、结直肠、乳腺及卵巢癌肿瘤标志物,对我国检验医学指南的编写与应用也有一定的借鉴作用。本刊特在本期刊发,以飨广大读者。 | 鄢盛恺 Ulf-Hkan Stenman Rolf Lamerz Leendert H.Looijenga Nils Brünner Michael J.Duffy Caj Haglund Mads Holten-Andersen Hans JФrgen Nielsen Francisco J.Esteva Nadia Harbeck Daniel F.Hayes Rafael Molina Daniel W.Chan Robert C.Bast Jr Ie-Ming Shih Lori J.Sokoll Gyrgy Slétormos 刘洋 梁红艳 姜晓峰 田亚平 薛丽 林文涛 顾兵 潘世扬 沈文梅 郑磊 李江 | 2012 | 临床检验杂志2012，30，2： | 32 |
| 2 | Expression of insulin receptor mRNA and insulin receptor sub- strate 1 in pancreatic islet beta-cells显示文摘 | Harbeck MC Louie DC Howland J | 1996 | Diabetes1996，45，6： | 1 |
| 3 | Locally recurrent or me- tastatic breast cancer:ESMO Clinical Practice Guidelines for diag- nosis,treatment and follow-up显示文摘 | Cardoso F Harbeck N Fallowfield L | 2012 | Ann Oncol2012，23，7： | 1 |
| 4 | Enhanced benefit fi'om adjuvant chemotherapy in breast cancer patients classified high-risk accoding to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor typel ( N = 3424) 显示文摘 | Harbeck N Kates RE Look MP Meijer-van Gelder ME Klijn JGM Kruger A | 2002 | Cancer Res2002，2，16： | 1 |
| 5 | Urekinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer 显示文摘 | HARBECK N KATES R E SCHMITr M | 2004 | Clin Breast Cancer2004，5，5： | 1 |
| 6 | Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy 显示文摘 | Schmitt M Harbeck N Thomssen C | 1997 | Thromb Haemost1997，78，1： | 1 |
| 7 | uPAand PAIl in primary breast cancer:from bench to beds/de显示文摘 | Nadia Harbeck Manfred Schmitt Christoph Thomssen E12 | 2004 | European Journal of Cancer Supplements2004，2，3： | 1 |
| 8 | The patient experience显示文摘 | HARBECK N HAIDINGER R | 2007 | Breast Cancer Res Treat2007，105，1： | 1 |
| 9 | Application of nearinfrared spectroscopy in the sugar industry for the detection of betaine显示文摘 | Harbeck C Faurie R Scheper T | 2004 | Analytica Chimica Acta2004，501，2： | 1 |
| 10 | Future Oncology显示文摘 | Harbeck N | | 0，，10： | 1 |
| 11 | A simple Duplex-PCR to evaluate the DNA quality of anthropological and forensic samples prior short tandem repeat typing显示文摘 | yon Wurmb-Schwark N Schwark T Harbeck M | 2004 | Legal Medicine2004，6，： | 1 |
| 12 | DNA methylation markers predict outcome in node-positive,estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy显示文摘 | Hartmann O Spyratos F Harbeck N | 2009 | Clin Cancer Res2009，15，1： | 1 |
| 13 | Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer显示文摘 | Harbeck N Kates PE Schmitt M | 2004 | Clin Breast Cancer2004，5，5： | 1 |
| 14 | Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase UI trials显示文摘 | Miles D Harbeck N Escudier B | 2011 | J Clin Oncol2011，，： | 1 |
| 15 | Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma显示文摘 | Dorn J Harbeck N Kates R | 2006 | Biol Chem2006，387，8： | 1 |
| 16 | Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cells显示文摘 | Harbeck MC Louie DC Howland J | 1996 | Diabetes1996，45，： | 1 |
| 17 | Triple-negative highrisk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy:results of WSG AM01 trial显示文摘 | Gluz O Nitz UA Harbeck N | 2008 | Ann Oncol2008，19，5： | 1 |
| 18 | Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin 显示文摘 | Harbeck B Huttelmaier S Schluter K | 2000 | J Biol Chem2000，275，30： | 1 |
| 19 | ClinieaI impact of the plasminogen activation system in tumor invasion and metastasis:prognostic relevance and target for therapy显示文摘 | Harbeck N Thomssen C | 1997 | Thromb Hemost1997，78，1： | 1 |
| 20 | A new look at node-negative breast cancer显示文摘 | Harbeck N Thomssen C | 2011 | Oncologist2011，16，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员